ONYX Pharmaceuticals

Onyx At High Seen Poised To Reap 40% More In Any Takeover
Bloomberg
Tue, 06/26/12 - 12:02 pm
M&A
ONYX Pharmaceuticals
These Stocks Avoided the Market's Squeeze
Motley Fool
Sat, 06/23/12 - 12:02 pm
Celgene
Chelsea Therapeutics
ONYX Pharmaceuticals
Cramer: What Celgene’s Europe News Means
CNBC
Sat, 06/23/12 - 12:00 pm
Celgene
Revlimid
ONYX Pharmaceuticals
kidney cancer
liver cancer
FDA panel unanimously backs Onyx cancer drug
Yahoo/AP
Thu, 06/21/12 - 07:46 am
advisory panel
FDA
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
Onyx Pharma: FDA Panel Live Blog
TheStreet.com
Wed, 06/20/12 - 12:50 pm
ONYX Pharmaceuticals
FDA
advisory panels
Multiple Myeloma
Carfilzomib
[video] Onyx Pharma CEO on New Cancer Drug
CNBC
Mon, 06/4/12 - 05:57 pm
ONYX Pharmaceuticals
Anthony Coles
Bayer
regorafenib
gastrointestinal cancer
26 Drugs Facing FDA Approval in 2012
TheStreet.com
Wed, 05/2/12 - 11:12 am
drug approvals
FDA
Regeneron
ONYX Pharmaceuticals
Pfizer
Celgene
Arena Pharmaceuticals
Alexa
Gilead
Merck
Ironwood
Vivus
Navidea Biopharmaceuticals
NPS Pharmaceuticals
Raptor Pharmaceuticals
Santarus
Biogen Idec
Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Pharmalive
Sat, 04/28/12 - 12:50 pm
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Expensive Celgene Shares A Better Bet Than Most Biotechs
Seeking Alpha
Thu, 04/5/12 - 09:10 pm
Celgene
JNJ
ONYX Pharmaceuticals
Revlimid
Pfizer
Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST
Yahoo/Fly on the Wall
Tue, 04/3/12 - 10:12 am
ONYX Pharmaceuticals
regorafenib
GIST
Bayer
20 Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Sun, 03/25/12 - 11:38 am
Achillion
Amylin
Ariad Pharmaceuticals
Aveo Pharmaceutical
Cell Therapeutics
EXACT Sciences
Idenix
Exelixis
Halozyme
Lexicon Pharmaceuticals
Nektar
Momenta
ONYX Pharmaceuticals
Optimer Pharmaceuticals
PDL Biopharma
Questcor Pharmaceuticals
Santarus
Spectrum Pharmaceuticals
Regeneron
Vivus
Neutral Stance for Onyx Pharma
Yahoo/Zacks
Sat, 03/24/12 - 11:19 am
ONYX Pharmaceuticals
IPO Preview: Argos Therapeutics
Seeking Alpha
Wed, 02/29/12 - 10:05 am
IPOs
Argos
GSK
Novartis
Pfizer
ONYX Pharmaceuticals
Onyx Beats; Says 2012 Vital
Yahoo/Zacks
Sat, 02/25/12 - 09:16 am
ONYX Pharmaceuticals
3 Biotech Buyout Candidates for 2012
Motley Fool
Tue, 01/31/12 - 08:00 am
Vertex Pharmaceuticals
ONYX Pharmaceuticals
Acorda
Biogen Idec
GSK
Novartis
Bayer
Pfizer
Teva Pharmaceuticals
Merck
JNJ
6 Biotech Plays With High Risk/Reward Potential
Seeking Alpha
Sun, 01/22/12 - 12:20 pm
Vertex Pharmaceuticals
Chelsea Therapeutics
ONYX Pharmaceuticals
Amarin
Ariad Pharmaceuticals
Cell Therapeutics
2 High-Flying Biotechs Face a New Hurdle
Motley Fool
Thu, 01/19/12 - 10:57 am
Bayer
ONYX Pharmaceuticals
Aeterna Zentaris
regorafenib
Keryx
Onyx Colon Cancer Drug Juggles Survival Benefit With Serious Side Effects
TheStreet.com
Wed, 01/18/12 - 10:01 am
ONYX Pharmaceuticals
colon cancer
Bayer
regorafenib
Onyx Pharma CFO plugs cancer pipeline amid rumored sales process
Fierce Biotech
Fri, 01/13/12 - 09:29 am
ONYX Pharmaceuticals
Pfizer
Takeda
M&A
cancer
Nexavar

Pages